Related Experiment Videos
Varying charges for comparably effective cancer treatments
1Department of Radiation Oncology, UCLA Medical Center.
American Journal of Clinical Oncology
|August 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Aerosol particle analyzer.
Applied optics·2010
Examining the use of breast-conserving treatment for women with breast cancer in a managed care environment.
American journal of clinical oncology·2000
Structural barriers and facilitators in HIV prevention: a review of international research.
AIDS (London, England)·2000
Combining Statistical Modeling and Machine Learning for Prognostic Feature Selection in Cervical Cancer: A Retrospective Study Based on SEER 2004 to 2015 Data.
American journal of clinical oncology·2026
Executive Summary of the American Radium Society (ARS) Appropriate Use Criteria (AUC) for Adjuvant Therapy for Resected Adenocarcinoma of the Pancreas.
American journal of clinical oncology·2026
Immunotherapy in Colorectal Cancer: Novel Perspectives and Next Steps.
American journal of clinical oncology·2026
Pirtobrutinib in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Systematic Review.
American journal of clinical oncology·2026
Durvalumab Consolidation After Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Efficacy and Safety.
American journal of clinical oncology·2026
Effects of Glucagon-Like Peptide-1 Receptor Agonists on Upper Gastrointestinal Adverse Events in Patients Receiving Platinum Analog-Based Chemotherapy.
American journal of clinical oncology·2026
Intraoperative Hemodynamic Management and Cerebral Protection During Awake Craniotomy: Evidence-Based Approaches.
Anesthesiology research and practice·2026
Combined Enzyme-Responsive Nano-Peptide Drug with Photothermal Function for Effective Anti-Hepatocellular Carcinoma in Mice Model.
International journal of nanomedicine·2026
Pathologic Complete Response to Neoadjuvant Dual Checkpoint Blockade with Durvalumab Plus Tremelimumab in Advanced-Stage HCC: A Case Report.
Journal of hepatocellular carcinoma·2026